advertisement
Brubaker JW 11
Showing records 1 to 11 |
Display all abstracts from Brubaker JW118281 Difficult decisions, filtration surgery, and the heartbreak of the numeratorSamuelson TW
Journal of Cataract and Refractive Surgery 2024; 50: 97-103
117008 Omidenepag Isopropyl Versus Timolol in Patients With Glaucoma or Ocular Hypertension: Two Randomized Phase 3 Trials (SPECTRUM 4 and 3)Bacharach J; Brubaker JW
American Journal of Ophthalmology 2024; 263: 23-34
118281 Difficult decisions, filtration surgery, and the heartbreak of the numeratorDe Francesco T
Journal of Cataract and Refractive Surgery 2024; 50: 97-103
117008 Omidenepag Isopropyl Versus Timolol in Patients With Glaucoma or Ocular Hypertension: Two Randomized Phase 3 Trials (SPECTRUM 4 and 3)Evans DG
American Journal of Ophthalmology 2024; 263: 23-34
118281 Difficult decisions, filtration surgery, and the heartbreak of the numeratorAhmed IIK; Gedde SJ
Journal of Cataract and Refractive Surgery 2024; 50: 97-103
117008 Omidenepag Isopropyl Versus Timolol in Patients With Glaucoma or Ocular Hypertension: Two Randomized Phase 3 Trials (SPECTRUM 4 and 3)Lu F
American Journal of Ophthalmology 2024; 263: 23-34
118281 Difficult decisions, filtration surgery, and the heartbreak of the numeratorParanjpe VR
Journal of Cataract and Refractive Surgery 2024; 50: 97-103
117008 Omidenepag Isopropyl Versus Timolol in Patients With Glaucoma or Ocular Hypertension: Two Randomized Phase 3 Trials (SPECTRUM 4 and 3)Odani-Kawabata N; Yamabe T
American Journal of Ophthalmology 2024; 263: 23-34
118281 Difficult decisions, filtration surgery, and the heartbreak of the numeratorSingh K; Brubaker JW
Journal of Cataract and Refractive Surgery 2024; 50: 97-103
117008 Omidenepag Isopropyl Versus Timolol in Patients With Glaucoma or Ocular Hypertension: Two Randomized Phase 3 Trials (SPECTRUM 4 and 3)Wirta DL
American Journal of Ophthalmology 2024; 263: 23-34
118281 Difficult decisions, filtration surgery, and the heartbreak of the numeratorGrover DS; Fellman RL; Zhang AD; Barton K
Journal of Cataract and Refractive Surgery 2024; 50: 97-103